Where do Nuvectis Pharma, Inc.'s ratios come from?

Every ratio is computed from Nuvectis Pharma, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Returns
Return on equity	-154.4%+33.6pp	-188%-43.0pp	-145%+5.1pp	-150.1%-34.8pp	-115.3%+58.1pp
Return on assets	-97.8%+7.3pp	-105.1%-9.2pp	-96%+1.5pp	-97.4%-16.5pp	-80.9%+19.7pp
Liquidity
Current ratio	2.3×-0.1×	2.4×-0.7×	3.1×+0.4×	2.7×-0.6×	3.3×+1.2×
Quick ratio	2.3×-0.1×	2.4×-0.7×	3.1×+0.4×	2.7×-0.6×	3.3×+1.2×
Cash ratio	2.2×-0.1×	2.4×-0.7×	3.1×+0.4×	2.6×-0.6×	3.2×+1.2×
Per Share
Book value per share	$0.61-28.1%	$0.84-20.1%	$1.06+33.8%	$0.79-24.9%	$1.05+85.2%
Valuation
Market capitalization	$739.27M+335%	$193.39M+26.2%	$153.25M-8.1%	$166.73M-27.0%	$228.53M+119%
Price / book	52×+43.9×	10.5×+4.1×	6.4×-3.5×	9.9×-1.0×	10.9×+0.1×
Earnings yield	-3.7%+8.2pp	-13.7%+2.9pp	-16.6%-3.3pp	-13.2%-4.4pp	-8.8%+9.4pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Nuvectis Pharma, Inc.'s ratios come from?: Every ratio is computed from Nuvectis Pharma, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.